A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of the Effects of K201 Injection, 2 mg/mL on the Restoration of Sinus Rhythm in Subjects Who Are in Atrial Fibrillation.

Trial Profile

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of the Effects of K201 Injection, 2 mg/mL on the Restoration of Sinus Rhythm in Subjects Who Are in Atrial Fibrillation.

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Dec 2012

At a glance

  • Drugs JTV 519 (Primary) ; JTV 519 (Primary)
  • Indications Atrial fibrillation
  • Focus Pharmacodynamics
  • Acronyms RESTORATION
  • Sponsors Sequel Pharmaceuticals
  • Most Recent Events

    • 13 Jan 2010 Actual patient number (153) added as reported by ClinicalTrials.gov.
    • 13 Jan 2010 Actual end date (December 2009) added as reported by ClinicalTrials.gov.
    • 13 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top